Pro Share Advisors LLC Heron Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

  • $36.5 Billion
  • Q2 2024

A detailed history of Pro Share Advisors LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 13,869 shares of HRTX stock, worth $24,964. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,869
Previous 18,604 25.45%
Holding current value
$24,964
Previous $51,000 5.88%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$2.32 - $3.86 $10,985 - $18,277
-4,735 Reduced 25.45%
13,869 $48,000
Q1 2024

May 08, 2024
BUY
$1.71 - $3.06 $2,506 - $4,485
1,466 Added 8.55%
18,604 $51,000
Q4 2023

Feb 14, 2024
BUY
$0.54 - $1.82 $1,989 - $6,706
3,685 Added 27.39%
17,138 $29,000
Q3 2023

Nov 13, 2023
SELL
$0.97 - $1.8 $13 - $25
-14 Reduced 0.1%
13,453 $13,000
Q2 2023

Aug 10, 2023
BUY
$1.11 - $2.88 $1,504 - $3,902
1,355 Added 11.19%
13,467 $15,000
Q1 2023

May 11, 2023
SELL
$1.51 - $3.25 $1,706 - $3,672
-1,130 Reduced 8.53%
12,112 $18,000
Q4 2022

Feb 02, 2023
BUY
$2.25 - $4.67 $4,270 - $8,863
1,898 Added 16.73%
13,242 $33,000
Q3 2022

Nov 04, 2022
SELL
$2.66 - $5.37 $579 - $1,170
-218 Reduced 1.89%
11,344 $48,000
Q2 2022

Aug 01, 2022
SELL
$2.3 - $6.29 $13,252 - $36,242
-5,762 Reduced 33.26%
11,562 $32,000
Q1 2022

May 10, 2022
SELL
$4.63 - $9.94 $13,065 - $28,050
-2,822 Reduced 14.01%
17,324 $99,000
Q4 2021

Feb 08, 2022
BUY
$8.35 - $12.6 $69,371 - $104,680
8,308 Added 70.18%
20,146 $184,000
Q3 2021

Nov 12, 2021
SELL
$10.13 - $15.0 $122,876 - $181,950
-12,130 Reduced 50.61%
11,838 $127,000
Q2 2021

Aug 13, 2021
BUY
$13.27 - $18.48 $7,311 - $10,182
551 Added 2.35%
23,968 $372,000
Q1 2021

May 14, 2021
BUY
$14.49 - $20.72 $57,988 - $82,921
4,002 Added 20.61%
23,417 $380,000
Q4 2020

Feb 09, 2021
BUY
$14.61 - $22.14 $126,712 - $192,020
8,673 Added 80.74%
19,415 $411,000
Q3 2020

Nov 13, 2020
SELL
$13.67 - $17.77 $15,966 - $20,755
-1,168 Reduced 9.81%
10,742 $159,000
Q2 2020

Aug 03, 2020
BUY
$10.89 - $21.47 $129,699 - $255,707
11,910 New
11,910 $175,000
Q1 2020

May 15, 2020
SELL
$10.23 - $24.56 $116,570 - $279,861
-11,395 Closed
0 $0
Q4 2019

Feb 12, 2020
BUY
$17.42 - $26.61 $198,500 - $303,220
11,395 New
11,395 $268,000
Q4 2018

Feb 14, 2019
SELL
$22.03 - $32.01 $185,756 - $269,908
-8,432 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$30.0 - $40.85 $840 - $1,143
28 Added 0.33%
8,432 $267,000
Q2 2018

Aug 13, 2018
BUY
$26.4 - $42.0 $221,865 - $352,968
8,404 New
8,404 $326,000

Others Institutions Holding HRTX

# of Institutions
188
Shares Held
129M
Call Options Held
94.7K
Put Options Held
148K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $214M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email